Context Therapeutics Announces Positive Interim Efficacy and Safety Results from Ongoing Phase 1 Clinical Trial for CTIM-76

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. ABBV
3. META
4. MU
5. SPY
6. ACN
7. NVDA
8. BLZE
9. IBM
10. PRIM

Go back to Context Therapeutics Announces Positive Interim Efficacy and Safety Results from Ongoing Phase 1 Clinical Trial for CTIM-76
(NASDAQ: CNTX) Delayed: 0.65 +0.02 (3.17%)
Previous Close $0.63    52 Week High $ 
Open $0.60    52 Week Low $ 
Day High $0.70    P/E N/A 
Day Low $0.59    EPS $ 
Volume 2,720,333       

(NASDAQ: CNTX) Delayed: 0.65 +0.02 (3.17%)
Previous Close $0.63    52 Week High $ 
Open $0.60    52 Week Low $ 
Day High $0.70    P/E N/A 
Day Low $0.59    EPS $ 
Volume 2,720,333